HIV type 1 genetic diversity is a major obstacle for antiretroviral drug resistance hybridization-based assays

AIDS Research and Human Retroviruses

Volumn 17, Issue 15, 2001, Pages 1415-1421

  Kijak, Gustavo H ^a   Rubio, Andrea E ^a   Quarleri, Jorge F ^a   Salomón, Horacio ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; RNA DIRECTED DNA POLYMERASE; VIRUS RNA;

ARGENTINA; ARTICLE; CODON; CONTROLLED STUDY; DEVICE; DRUG RESISTANCE; GENE PROBE; GENE STRUCTURE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYBRIDIZATION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL;

BASE SEQUENCE; DNA, VIRAL; DRUG RESISTANCE, VIRAL; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID HYBRIDIZATION; PHYLOGENY; RECOMBINATION, GENETIC; VARIATION (GENETICS);

EID: 0034754725     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922201753197088     Document Type: Article

References (31)

1. Understanding the genetic diversity of HIV-1
2. Genetic diversity of HIV-1: The moving target
3. HIV-1 nomenclature proposal. A reference guide to HIV-1 classification
4. HIV type 1 subtypes in Argentina and genetic heterogeneity of the V3 region
5. Coexistence of subtypes B, F, and as B/F env recombinant of HIV type 1 in Buenos Aires, Argentina
6. Identification of human immunodeficiency virus type 1 subtypes B, F and B/F recombinant and dual infection with these subtypes in Argentina
7. Evidence of high frequency of HIV-1 subtype F in heterosexual population in Buenos Aires, Argentina
8. Genetic epidemiology of HIV-1 infected maternity patients and their sexual partners in Buenos Aires, Argentina
9. Widespread circulation of a B/F intersubtype recombinant form among HIV-1-infected individuals in Buenos Aires, Argentina
10. Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy
11. Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene
12. Drug-resistance genotyping in HIV-1 therapy: The VIRADAPT randomised controlled trial
13. A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy
14. Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals
15. A highly prevalent polymorphism at codon 72 of the HIV-1 reverse transcriptase in Argentina prevents hybridization reaction at codon 74 in the LiPA genotyping test
16. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
17. Confidence limits on phylogenies: An approach using the bootstrap
18. TREEVIEW: An application to display phylogenetic trees on personal computers
19. Numbering positions in HIV relative to HXB2CG
20. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination
21. Recombination in AIDS
22. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)
23. Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2′, 3′-dideoxy-cytidine
24. Assay of plasma samples representing different HIV-1 genetic subtypes: An evaluation of new versions of the Amplicor HIV-1 Monitor assay
25. Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes
26. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes
27. Impact of HIV type 1 subtype variation on viral RNA quantitation
28. Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina